Karen Afenjar

Articles by Karen Afenjar

23 Clinical Outcomes in Patients With HR+/HER2− Early Breast Cancer By Prior Systemic Treatment: A Subgroup Analysis of the NATALEE Trial

ByNicholas McAndrew,Stephen Chia,Fabio Puglisi,Aditya Bardia, MD, MPH, FASCO,Yann Izarzugaza,Christian Schem, MD,Binghe Xu,Fanny Le Du,Priyanka Sharma, MD,Karen Afenjar,Murat Akdere,Juan Pablo Zarate,Yogesh Chattar,Peter A. Fasching

June 23rd 2025

Latest Updated Articles

23 Clinical Outcomes in Patients With HR+/HER2− Early Breast Cancer By Prior Systemic Treatment: A Subgroup Analysis of the NATALEE Trial
June 23rd 2025

Trending on CancerNetwork

Lutetium Lu 177 Dotatate Biosimilar Earns Final FDA Approval in GEP-NETs

Rusfertide Earns Category 1 NCCN Recommendation in Polycythemia Vera

PANXEON Liquid Biopsy Demonstrates Potential for Detecting Early Pancreatic Cancer

Novel Monoclonal Antibody Wins FDA Fast Track Designation in High-Risk MDS

Distinguishing HER2 Mutations From Amplification in NSCLC Testing